All posts by Steven Novella

Founder and currently Executive Editor of Science-Based Medicine Steven Novella, MD is an academic clinical neurologist at the Yale University School of Medicine. He is also the host and producer of the popular weekly science podcast, The Skeptics’ Guide to the Universe, and the author of the NeuroLogicaBlog, a daily blog that covers news and issues in neuroscience, but also general science, scientific skepticism, philosophy of science, critical thinking, and the intersection of science with the media and society. Dr. Novella also has produced two courses with The Great Courses, and published a book on critical thinking - also called The Skeptics Guide to the Universe.

Variants of Interest

The World Health Organization and medical experts are keeping an eye on new variants as the pandemic simmers on.

/ September 8, 2021

Using Evolutionary Principles to Reduce Antibiotic Resistance

We need to harness all options to delay the inevitable emergence of antibiotic resistance.

/ September 1, 2021

Vaccines Vaccines and more Vaccines

COVID vaccines are dominating the health news, and with good reason.

/ August 25, 2021

Philippines Approves Golden Rice

Golden rice passes the final regulatory hurdle in the Philippines. Farming can now start planting.

/ August 18, 2021

Buzzword Medicine – Anti-Proinflammation

Does it make sense to simultaneously recommend interventions to suppress and boost the immune system?

/ August 11, 2021

Neurological Manifestations of COVID

The more we study COVID, the more apparent it is that neurological symptoms are common and can be long lasting.

/ August 4, 2021

Olympic Pseudoscience – Tokyo Edition

Pseudosciences come and go with the Olympics.

/ July 28, 2021

Fake Homeopathy COVID Scam

A naturopath was arrested for selling fake homeopathic COVID treatments, which reveals the "alternative" rot in the medical system.

/ July 21, 2021

When Will We Need a COVID Vaccine Booster?

COVID vaccine boosters are not needed yet, but scientists are following the data.

/ July 14, 2021

FDA’s Decision to Approve Aduhelm (aducanumab) for Alzheimer’s

Criticism of the FDA's decision to approve aducanumab for Alzheimer's disease.

/ July 7, 2021